Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort

BACKGROUND: The risk of dementia is higher in women than men. The metabolic consequences of estrogen decline during menopause accelerate neuropathology in women. The use of hormone replacement therapy (HRT) in the prevention of cognitive decline has shown conflicting results. Here we investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Rasha N. M., Hornberger, Michael, Ritchie, Craig W., Minihane, Anne Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830747/
https://www.ncbi.nlm.nih.gov/pubmed/36624497
http://dx.doi.org/10.1186/s13195-022-01121-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830747/
https://www.ncbi.nlm.nih.gov/pubmed/36624497
http://dx.doi.org/10.1186/s13195-022-01121-5

Ejemplares similares